Company intelligence / Profile preview
Hawaii Biotech
Honolulu, Hawaii, United Stateshibiotech.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
The company has sold one of its lead vaccine candidates to a large pharmaceutical partner after obtaining safety and immunogenicity data from initial clinical studies[6]. They have a strong track record of securing non-dilutive funding from grants and contracts from NIH and DoD[6].
- Therapeutic areas
- Infectious Diseases
- Modalities
- Recombinant subunit protein vaccinesSmall molecule drugs
- Industry
- Biotech
02
Drug pipeline
14 assets13 more assets in the full pipeline.
03
Partnerships
Has partnered with a "large pharmaceutical partner" (specific name not provided)[6]
Beyond the preview
Go deeper on Hawaii Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hawaii Biotech.